Moleculin to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
HOUSTON, Sept. 17, 2021 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter Klemp, President and…
Comments Off on Moleculin to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit